P-039: ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT): A PROSPECTIVE TRIAL EVALUATING TRANSFUSION UTILIZATION AND THE FEASIBILITY OF PHARMACOKINETIC HYDROXYUREA DOSING IN CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA

• POWER-HAYS, MD,
• A.,
• NAMAZZI R., MBCHB, MMED,
• KATO C., MD,
• CONROY A., PHD,
• HUME H., MD, FRCPC,
• JOHN C., MD, MS,
• STUBER, MA S.,
• LANE A., PHD,
• LATHAM T., MA,
• OPOKA R., MBCHB, PHD,
• WARE R., MD, PHD

Affiliations

POWER-HAYS, MD

A.

1 Cincinnati Children’s Hospital Medical Center, Cancer and Blood Diseases Institute, Cincinnati, UNITED STATES

NAMAZZI R., MBCHB, MMED

2 Global Health Uganda, Kampala, UGANDA

KATO C., MD

2 Global Health Uganda, Kampala, UGANDA

CONROY A., PHD

2 Global Health Uganda, Kampala, UGANDA

HUME H., MD, FRCPC

5 CHU Sainte-Justine, Department of Paediatrics, University of Montreal, Montreal, CANADA

JOHN C., MD, MS

2 Global Health Uganda, Kampala, UGANDA

STUBER, MA S.

1 Cincinnati Children’s Hospital Medical Center, Cancer and Blood Diseases Institute, Cincinnati, UNITED STATES

LANE A., PHD

1 Cincinnati Children’s Hospital Medical Center, Cancer and Blood Diseases Institute, Cincinnati, UNITED STATES

LATHAM T., MA

1 Cincinnati Children’s Hospital Medical Center, Cancer and Blood Diseases Institute, Cincinnati, UNITED STATES

OPOKA R., MBCHB, PHD

2 Global Health Uganda, Kampala, UGANDA

WARE R., MD, PHD

1 Cincinnati Children’s Hospital Medical Center, Cancer and Blood Diseases Institute, Cincinnati, UNITED STATES